<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Forest Laboratories</title>
    <link>http://www.newstin.co.uk/uk/FOREST_LABORATORIES</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Forest Laboratories - News</title>
      <link>http://www.newstin.co.uk/uk/FOREST_LABORATORIES</link>
      <description>You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.&lt;br/&gt;Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. &lt;a href="http://corp.newstin.com/static.a?tpl=corp_rss"&gt;Read more about Newstin Pro RSS&lt;/a&gt; or &lt;a href="http://corp.newstin.com/files/corp/newstin_prorss.pdf"&gt;download the product presentation now&lt;/a&gt;.</description>
      <pubDate>Sun, 08 Nov 2009 01:54:14 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/FOREST_LABORATORIES</guid>
      <dc:date>2009-11-08T01:54:14Z</dc:date>
    </item>
    <item>
      <title>Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin...</title>
      <link />
      <description />
      <pubDate>Sat, 07 Nov 2009 12:09:47 GMT</pubDate>
      <guid />
      <dc:date>2009-11-07T12:09:47Z</dc:date>
    </item>
    <item>
      <title>Wedgewood Pharmacy Compounds Thyroid Tablets During Manufacturer Backorder of Armour Thyroid Tablets</title>
      <link />
      <description />
      <pubDate>Thu, 05 Nov 2009 16:06:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-05T16:06:00Z</dc:date>
    </item>
    <item>
      <title>Third-quarter financial results for the year 2009 announced by Biovail</title>
      <link />
      <description />
      <pubDate>Thu, 05 Nov 2009 13:02:24 GMT</pubDate>
      <guid />
      <dc:date>2009-11-05T13:02:24Z</dc:date>
    </item>
    <item>
      <title>Bulls Target UnitedHealth: Options Recap</title>
      <link />
      <description />
      <pubDate>Thu, 05 Nov 2009 00:24:37 GMT</pubDate>
      <guid />
      <dc:date>2009-11-05T00:24:37Z</dc:date>
    </item>
    <item>
      <title>"Of Mutual Interest"-Bruce Berkowitz, Portfolio Manager for Fairholme Fund</title>
      <link />
      <description />
      <pubDate>Wed, 04 Nov 2009 02:59:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-04T02:59:00Z</dc:date>
    </item>
    <item>
      <title>A CEO and His Son</title>
      <link />
      <description />
      <pubDate>Wed, 04 Nov 2009 07:54:22 GMT</pubDate>
      <guid />
      <dc:date>2009-11-04T07:54:22Z</dc:date>
    </item>
    <item>
      <title>Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot...</title>
      <link />
      <description />
      <pubDate>Wed, 04 Nov 2009 12:00:43 GMT</pubDate>
      <guid />
      <dc:date>2009-11-04T12:00:43Z</dc:date>
    </item>
    <item>
      <title>High energy rewards for option trader at RRI</title>
      <link />
      <description />
      <pubDate>Tue, 03 Nov 2009 19:08:20 GMT</pubDate>
      <guid />
      <dc:date>2009-11-03T19:08:20Z</dc:date>
    </item>
    <item>
      <title>Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...</title>
      <link />
      <description />
      <pubDate>Tue, 03 Nov 2009 03:08:35 GMT</pubDate>
      <guid />
      <dc:date>2009-11-03T03:08:35Z</dc:date>
    </item>
  </channel>
</rss>

